← Back to Clinical Trials
Recruiting NCT06090240

NCT06090240 Motivational Interviewing to Enhance Advance Care Planning for Older Adults and Caregivers After Emergency Visits

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06090240
Status Recruiting
Phase
Sponsor The University of Hong Kong
Condition Older Adults
Study Type INTERVENTIONAL
Enrollment 300 participants
Start Date 2023-12-14
Primary Completion 2026-07-31

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Dyadic MI-ACP interventionElderly alone MI-ACP

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 300 participants in total. It began in 2023-12-14 with a primary completion date of 2026-07-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate the effectiveness of a motivational interviewing (MI) intervention in enhancing advance care planning (ACP) among older adults who have visited the Emergency Room (ER) in the past six months and their family caregivers. The main question it aims to answer is: The effectiveness of the MI-based ACP intervention implemented within six months of an ER visit on improving older adults' advance directives (AD) completion rate. Compared to participants in the control group who will only receive a self-education booklet, participants in the intervention group will receive a motivational interview educational intervention to see the effectiveness of an MI-based ACP intervention implemented within six months following an emergency room visit regarding the completion of AD for older adults.

Eligibility Criteria

The target group will be dyads comprising older adults who have had ER visits within the previous six months and their family caregivers. A dyad is defined as one older adult and one primary family caregiver of the older adult. For older adults: Inclusion Criteria: * Aged 65 or older * At least one episode of ER visit in the last six months * Has a family caregiver to be present during the intervention * Able to communicate in Chinese Exclusion Criteria: * Has completion of an AD * Moderate to severe cognitive impairment or diagnosis of dementia, as identified in health records * Communication problems (e.g., deafness or aphasia) For family caregivers: Inclusion Criteria: * Aged 18 or above * Immediate or extended family member or friend nominated by an eligible older adult participant as primary caregiver * Able to communicate in Chinese Exclusion Criteria: * Moderate to severe cognitive impairment * Communication problems (e.g., deafness or aphasia)

Contact & Investigator

Central Contact

Chia-Chin LIN, PhD,FAAN,RN

✉ cclin@hku.hk

📞 852-3917-6600

Principal Investigator

Chia-Chin LIN, PhD,FAAN,RN

PRINCIPAL INVESTIGATOR

University of Hong Kong, School of Nursing

Frequently Asked Questions

Who can join the NCT06090240 clinical trial?

This trial is open to participants of all sexes, studying Older Adults. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06090240 currently recruiting?

Yes, NCT06090240 is actively recruiting participants. Contact the research team at cclin@hku.hk for enrollment information.

Where is the NCT06090240 trial being conducted?

This trial is being conducted at Hong Kong, Hong Kong.

Who is sponsoring the NCT06090240 clinical trial?

NCT06090240 is sponsored by The University of Hong Kong. The principal investigator is Chia-Chin LIN, PhD,FAAN,RN at University of Hong Kong, School of Nursing. The trial plans to enroll 300 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology